FdaApplication
NDA 022047
Identifiers
- fda_app_no: NDA022047
Properties
| Property | Value |
|---|---|
| applicant_name | CHEPLAPHARM ARZNEIMITTEL GMBH |
| application_type | NDA |
| approval_date | 2007-05-17 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SEROQUEL XR | QUETIAPINE FUMARATE | EQ 400MG BASE | TABLET, EXTENDED RELEASE;ORAL |
| SEROQUEL XR | QUETIAPINE FUMARATE | EQ 150MG BASE | TABLET, EXTENDED RELEASE;ORAL |
| SEROQUEL XR | QUETIAPINE FUMARATE | EQ 300MG BASE | TABLET, EXTENDED RELEASE;ORAL |
| SEROQUEL XR | QUETIAPINE FUMARATE | EQ 200MG BASE | TABLET, EXTENDED RELEASE;ORAL |
| SEROQUEL XR | QUETIAPINE FUMARATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE;ORAL |
5 products